Oil-in-Water Nanosized Emulsions for Drug Delivery and Targeting
Regular price
€246.70
A01=Tamilvanan Shunmugaperumal
Author_Tamilvanan Shunmugaperumal
Category=MQP
Category=PNB
Category=PNR
Category=TCB
Category=TDC
cationic nanosized emulsions
emulsions
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_science
eq_tech-engineering
generations
medicament loadings
nanosized emulsions
oil-in-water nanosized emulsions
overview
oxygen-carrying emulsions
safety assessment
therapeutical applications
tocol-based emulsions
Product details
- ISBN 9781119585220
- Weight: 482g
- Dimensions: 10 x 10mm
- Publication Date: 09 Mar 2021
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
Secure
checkout
Fast Shipping
Easy returns
This book combines emulsion knowledge into a single, comprehensive volume, ideal for professionals and students involved in the areas of pharmaceutical science who are looking to learn about this emergent research concept.
- Compiles the step-by-step investigations made concerning the potential of nanosized emulsions on both drug delivery and drug targeting areas by different group of scientists in various laboratories across the world
- Inverts the common nano-emulsions coverage trend of focusing on focused on the particulate system itself, instead exploring the way to turn nanosized emulsions as biomedical tool, as well as, treating the in vitro and in vivo aspects after administration
- Provides an overview of the current state-of-the art regarding the development of tocol emulsions, emulsion adjuvants in immunization research, oxygen-carrying emulsions (called as fluorocarbon emulsion) and emulsions for delivering drugs to nasal and topical (ocular and transdermal) routes
Tamilvanan Shunmugaperumal, PhD, works at the National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India. His current research focuses on systematic optimization of formula to prepare various pharmaceutical dosage forms such as solid lipid microparticles, nanosized emulsions, and microspheres, where he seeks to exploit the potential of lipid- and polymer-based drug delivery carriers to eradicate infectious biofilm formation associated with both medical devices and human organs.
